Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Blood
|
June 15, 2023
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, et al.
Blood
|
December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium
Mark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma
Ian W Flinn, Carole B Miller, Kirit M Ardeshna, et al.
Blood
|
March 19, 2020
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
Gaurav Goyal, Mark L Heaney, Matthew Collin, et al.
Blood Advances
|
October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma
J Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Blood
|
April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Philippe Armand, Yi-Bin Chen, Robert A Redd, et al.
Blood Advances
|
April 3, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, et al.
Annals of Hematology
|
October 18, 2023
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma
Reid W Merryman, Robert A Redd, Arnold S Freedman, et al.
Annals of Hematology
|
July 25, 2021
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study
Won Seog Kim, Yasuhiro Oki, Seok Jin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Owen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Blood
|
June 15, 2023
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, et al.
Blood
|
December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium
Mark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma
Ian W Flinn, Carole B Miller, Kirit M Ardeshna, et al.
Blood
|
March 19, 2020
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
Gaurav Goyal, Mark L Heaney, Matthew Collin, et al.
Blood Advances
|
October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma
J Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Blood
|
April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Philippe Armand, Yi-Bin Chen, Robert A Redd, et al.
Blood Advances
|
April 3, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, et al.
Annals of Hematology
|
October 18, 2023
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma
Reid W Merryman, Robert A Redd, Arnold S Freedman, et al.
Annals of Hematology
|
July 25, 2021
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study
Won Seog Kim, Yasuhiro Oki, Seok Jin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Owen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
Page
of 5